Benaroya Research Institute

Learn About Our
Research Programs

This program focuses on identifying the causes and cures of Type 1 (autoimmune) diabetes through basic and clinical research.
This program's mission is to understand the relationship between the immune system and diseases and to design new therapies.
This program acts as an interface between the laboratory researchers, clinicians and patients to translate scientific knowledge into clinical trials.
This program focuses on diseases of the body’s tissues, heart and blood vessels—and conducts basic and translational research.
This program conducts clinical trials of new therapeutics, and studies clinical outcomes.
Learn about our researchers.

How BRI Can Help You

Benaroya Research Institute at Virginia Mason (BRI) is an international leader in immune system and autoimmune disease research translating discoveries to real life applications. BRI is one of the few research institutes in the world dedicated to finding causes and cures to eliminate autoimmune diseases including Type 1 diabetes, arthritis, lupus, multiple sclerosis, scleroderma and many others.

Much of our emphasis is on solving the puzzle of autoimmune conditions by unlocking the mysteries of the immune system. Our medical research investigating diseases at genetic and molecular levels is being translated into understanding how these approaches can be applied to patients and at-risk individuals. We are now using these therapies and discoveries in clinical research and trials to bring new medical advances to people at the earliest opportunity.

Find out more about autoimmune diseases and what we are doing:

How to Participate

News & Events

  • Boeing Classic, the Annual PGA TOUR Champions Tour Event, to Benefit BRI in 2010 Read more
  • Benaroya Research Institute Receives $7 Million for Vaccine Study Read more
  • Dr. Bettelli Joins BRI to Enhance Multiple Sclerosis Research Read more